Literature DB >> 24507838

Cellular and molecular mechanisms of chronic obstructive pulmonary disease.

Peter J Barnes1.   

Abstract

Chronic obstructive pulmonary disease is associated with chronic inflammation affecting predominantly lung parenchyma and peripheral airways and results in largely irreversible and progressive airflow limitation. This inflammation is characterized by increased numbers of alveolar macrophages, neutrophils, and T lymphocytes, which are recruited from the circulation. Oxidative stress plays a key role in driving this inflammation. The pulmonary inflammation may enhance the development and growth of lung cancer. The peripheral inflammation extends into the circulation, resulting in systemic inflammation with the same inflammatory proteins. Systemic inflammation may worsen comorbidities. Treatment of pulmonary inflammation may therefore have beneficial effects.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autoantibody; Chemokine; Cytokine; Inflammation; Macrophage; Neutrophil; Nuclear factor-κB; Oxidative stress

Mesh:

Year:  2013        PMID: 24507838     DOI: 10.1016/j.ccm.2013.10.004

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  137 in total

Review 1.  Mitochondrial Dysfunction in Airway Disease.

Authors:  Y S Prakash; Christina M Pabelick; Gary C Sieck
Journal:  Chest       Date:  2017-03-21       Impact factor: 9.410

Review 2.  Airway hydration and COPD.

Authors:  Arunava Ghosh; R C Boucher; Robert Tarran
Journal:  Cell Mol Life Sci       Date:  2015-06-12       Impact factor: 9.261

3.  A-kinase-anchoring proteins coordinate inflammatory responses to cigarette smoke in airway smooth muscle.

Authors:  Wilfred J Poppinga; Irene H Heijink; Laura J Holtzer; Philipp Skroblin; Enno Klussmann; Andrew J Halayko; Wim Timens; Harm Maarsingh; Martina Schmidt
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-01-30       Impact factor: 5.464

Review 4.  A Decade of National Heart, Lung, and Blood Institute Programs Supporting COPD Research and Education .

Authors:  Lisa Postow; Antonella Punturieri; Thomas L Croxton; Gail G Weinmann; James P Kiley
Journal:  Chronic Obstr Pulm Dis       Date:  2014-05-06

5.  Regulation of Retinoic Acid Receptor Beta by Interleukin-15 in the Lung during Cigarette Smoking and Influenza Virus Infection.

Authors:  Jianmiao Wang; Wei Liu; Chad Marion; Rajvir Singh; Nathaniel Andrews; Chun Geun Lee; Jack A Elias; Charles S Dela Cruz
Journal:  Am J Respir Cell Mol Biol       Date:  2015-12       Impact factor: 6.914

6.  IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras-Mutant Lung Cancer.

Authors:  Mauricio S Caetano; Huiyuan Zhang; Amber M Cumpian; Lei Gong; Nese Unver; Edwin J Ostrin; Soudabeh Daliri; Seon Hee Chang; Cesar E Ochoa; Samir Hanash; Carmen Behrens; Ignacio I Wistuba; Cinthya Sternberg; Humam Kadara; Carlos Gil Ferreira; Stephanie S Watowich; Seyed Javad Moghaddam
Journal:  Cancer Res       Date:  2016-04-01       Impact factor: 12.701

Review 7.  Smoking, inflammation and small cell lung cancer: recent developments.

Authors:  Gerhard Hamilton; Barbara Rath
Journal:  Wien Med Wochenschr       Date:  2015-08-20

Review 8.  Immune Dysfunction in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Tariq A Bhat; Louis Panzica; Suresh Gopi Kalathil; Yasmin Thanavala
Journal:  Ann Am Thorac Soc       Date:  2015-11

Review 9.  Non-infectious Pulmonary Diseases and HIV.

Authors:  M Triplette; K Crothers; E F Attia
Journal:  Curr HIV/AIDS Rep       Date:  2016-06       Impact factor: 5.071

Review 10.  Therapeutic Monoclonal Antibodies for the Treatment of Chronic Obstructive Pulmonary Disease.

Authors:  Maria Gabriella Matera; Clive Page; Paola Rogliani; Luigino Calzetta; Mario Cazzola
Journal:  Drugs       Date:  2016-09       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.